Savara (SVRA) Total Non-Current Liabilities (2016 - 2025)

Savara's (SVRA) quarterly Total Non-Current Liabilities came in at $50.3 million in Q4 2025, up 21.67% year-on-year from $41.3 million in Q4 2024, and up 8.09% on a QoQ basis from $46.5 million in Q3 2025.

Savara (SVRA) Total Non-Current Liabilities (2016 - 2025) Analysis & Trends

Savara (SVRA) has 10 years of Total Non-Current Liabilities data on file, last reported at $50.3 million in Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities rose 21.67% year-over-year to $50.3 million in Q4 2025; TTM through Dec 2025 was $50.3 million, a 21.67% increase from a year earlier, with the FY2025 full-year figure at $50.3 million, up 21.67% from the prior year.
  • Total Non-Current Liabilities for Q4 2025 stood at $50.3 million, up from $46.5 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for SVRA reached as high as $50.3 million in Q4 2025 and fell as low as $29.6 million in Q1 2022.
  • Historically, Total Non-Current Liabilities has averaged $36.1 million across 5 years, with a median of $33.8 million in 2021.
  • Across the five-year window, Total Non-Current Liabilities grew 21.73% in 2021 and slipped 8.69% in 2022, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $32.0 million in 2021, then slipped by 0.12% to $31.9 million in 2022, then gained by 15.65% to $36.9 million in 2023, then gained by 11.9% to $41.3 million in 2024, then rose by 21.67% to $50.3 million in 2025.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $50.3 million in Q4 2025, $46.5 million in Q3 2025, and $43.3 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 4.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.28 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.98 Bn
4 NuCana 279.75 Bn 279.75 Bn - 949,738.67
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 746.94 Mn
10 Savara 1.24 Bn 1.24 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 50.30 Mn
Sep 30, 2025 46.54 Mn
Jun 30, 2025 43.28 Mn
Mar 31, 2025 41.42 Mn
Dec 31, 2024 41.34 Mn
Sep 30, 2024 39.34 Mn
Jun 30, 2024 37.77 Mn
Mar 31, 2024 36.23 Mn
Dec 31, 2023 36.95 Mn
Sep 30, 2023 35.24 Mn
Jun 30, 2023 32.10 Mn
Mar 31, 2023 31.07 Mn
Dec 31, 2022 31.95 Mn
Sep 30, 2022 31.17 Mn
Jun 30, 2022 29.65 Mn
Mar 31, 2022 29.63 Mn
Dec 31, 2021 31.98 Mn
Sep 30, 2021 32.01 Mn
Jun 30, 2021 31.02 Mn
Mar 31, 2021 32.45 Mn